andrew huberman bpc 157 recommendations What are the benefits of 157? Dr. Andrew Huberman — Peptides,

Once the 28-day window expires, discard the vial even if it appears clear

The packaging was very secure and everything looks high quality

This 10-unit dose is commonly used as a starting point for KLOW protocols

The peptide displays a favorable safety profile in preclinical settings with minimal irritation

Although the magnitude of the A 1c change is small, it is consistent with the expectations for antidiabetic agents administered to subjects having excellent baseline control, and is similar to what has been observed in previous clinical trials evaluating antidiabetic agents (39)

PubMed reference (NNMT inhibition & metabolic health)